Use the FDA's pensions calculator to give you a better idea of what the changes to pension arrangements from 2015 (as set out in the Government's final offer) might mean for you.
Q&A: What is meant by significant and sustained industrial action?
Public sector pensions are affordable
Pay comparability: what are the facts?
Increased pension contributions - no justification
Read the full FDA pensions campaign pack
FDA Response to Consultation on Proposed Increases to Contribution Rates
ARC News special issue - Fair Pay, Fair Pensions
Government civil service pensions formal offer (Heads of Agreement) - 15 December 2011
The FDA's ballot on the proposed civil service pension scheme from 2015 closed on Tuesday 8 May.
The result of the ballot was:
Accept - 73%
Reject - 27%
The turnout was 43%.
Dave Penman, FDA Deputy General Secretary, said:
"This result should not be interpreted as an endorsement by FDA members of the new scheme. FDA members remain deeply unhappy about aspects of the changes and the Government's approach to pension reform. The imposition of increases to pension contributions, and the Government's unilateral decision to devalue pensions in payment by switching the uprating index from RPI to CPI, has generated both anger and resentment.
"Members have seen their pay and living standards cut because of the 2012 increase in pension contributions imposed by the Government, alongside the continuing public sector pay freeze. This cut in living standards will be exacerbated by the further contribution increases planned for 2013 and 2014. These increases are nothing more than a levy on public sector workers, which the FDA has consistently opposed.
"The changes to pension arrangements, including the increases to contributions, will impact on the overall competitiveness of the total reward package. There is already considerable evidence that the pay levels of those in the more senior grades of the civil service are substantially below those for comparable jobs in the wider public and private sectors. A priority for the FDA in the coming months will be seeking action by employers and the Government to address these disparities in pay levels."